drugset / Trial / NCT02764125
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
RandomizedCrossoverQuadruple-blindTreatment
Summary
This will be a randomised, crossover, double-blind, double-dummy, active-controlled, multicentre, phase II proof-of-concept study in Parkinson's Disease (PD) patients with end-of-dose wearing-off (motor fluctuations).
Timeline
- Start
- 2016-04-08
- Primary completion
- 2018-03-27
- Completion
- 2018-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Entacapone | Small molecule | — | — |
| Subject | ODM-104 | Unknown | — | — |
| Background | Carbidopa | Unknown | — | — |
| Background | Levodopa | Small molecule | — | — |